Experts discuss the implications of Most Favored Nation pricing on U.S. drug costs, innovation and patient access in the ...

Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved ...

Vascular endothelial growth factor (VEGF) inhibitor, Eydenzelt (aflibercept-boav), is now approved to treat retinal disease ...

A recent study finds that despite biosimilar use rising to 60% to 86% for three cancer drugs, predicted savings don’t match ...

An expert discusses how insurance coverage barriers for Janus kinase (JAK) inhibitors in vitiligo treatment can be overcome ...

Jascayd targets the enzyme PDE4B, which plays a role in the inflammatory process. The new therapy is able to affect both ...

Although neuroendocrine tumors of the digestive system have been studied, far less is known about those that develop in the ...

Providing support and care for adults with schizophrenia can mean a significant personal and financial burden for family ...

The CDC updates vaccine schedules, emphasizing personalized decision-making for COVID-19 shots and recommending standalone ...

Researchers say ophthalmologists and optometrists were motivated, at least in part, to use the sutureless grafts for dry eye ...

In this interview, Steven Buslovich, M.D., CMD, MS, CMO of Senior Care at PointClickCare describes AI’s role in care ...

The differing regulation of key fibrotic pathways suggest that idiopathic pulmonary fibrosis involves dysregulation rather ...